Ian Read adds a new post to his growing roster of post-Pfizer positions — and this one pays well

Ian Read may have to pick up the pace a bit to meet the swelling number of jobs he’s added to his resume since recently retiring from Pfizer after a 41-year run that included 9 years at the top.